SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Press Releases
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test
February 26, 2026
 · 
6 min read
Press Releases
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
February 19, 2026
 · 
5 min read
Press Releases
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study
February 17, 2026
 · 
5 min read
Press Releases
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board
February 10, 2026
 · 
5 min read
Press Releases
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
January 8, 2026
 · 
5 min read
Press Releases
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable
December 3, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
November 17, 2025
 · 
11 min read
Press Releases
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
November 6, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases
October 29, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
October 21, 2025
 · 
4 min read
Load More
JOBS